The PART1 Antibody (PACO03791) is a valuable tool for researchers studying PART1, a novel long non-coding RNA (lncRNA) implicated in cancer progression and metastasis. This polyclonal antibody, produced in rabbits, exhibits high specificity and sensitivity in detecting PART1 in human samples, making it suitable for various research applications, including Western blotting.PART1 is known to play a crucial role in regulating gene expression and cellular functions involved in tumor growth and invasion. By targeting PART1, researchers can gain insights into the molecular mechanisms underlying cancer development and potentially identify therapeutic targets for cancer treatment.
The PART1 Antibody enables precise detection and analysis of PART1 expression in different cell types, making it an essential tool for studies in oncology and molecular biology.Overall, the PART1 Antibody offers researchers a reliable means to investigate the biological functions of PART1 and its implications in cancer biology. Its specificity and versatility make it an invaluable asset in unraveling the complexities of cancer progression and advancing the development of targeted therapies for cancer patients.
Antibody Name:
PART1 Antibody
Antibody SKU:
PACO03791
Size:
50ug
Host Species:
Rabbit
Tested Applications:
ELISA, IHC
Recommended Dilutions:
IHC:1:100-1:300
Species Reactivity:
Human
Immunogen:
synthesized peptide derived from the N-terminal region of human PART-1.
Form:
Liquid
Storage Buffer:
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Purification Method:
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
